California Culture Today
SEE OTHER BRANDS

The best news from California on culture and lifestyle

California Culture Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on California Culture Today.

Press releases published on August 27, 2025

Snail, Inc. to Present at the 2025 Gateway Conference on September 3, 2025 at 12:30 p.m. Pacific Time

Snail, Inc. to Present at the 2025 Gateway Conference on September 3, 2025 at 12:30 p.m. Pacific Time

CULVER CITY, Calif., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Snail, Inc. (Nasdaq: SNAL) (“Snail Games” or the “Company”), a leading global independent developer and publisher of interactive digital entertainment, is confirmed to present at the 2025 Annual …

Amaze to Present at the 2025 Gateway Conference on September 3

Amaze to Present at the 2025 Gateway Conference on September 3

NEWPORT BEACH, Calif., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Amaze Holdings, Inc. (NYSE American: AMZE) (“Amaze” or the “Company”), a global leader in creator-powered commerce, is confirmed to present at the 2025 Annual Gateway Conference, which is being held …

Commure Ambient AI Scores High Marks in KLAS First Look Report for Automating Provider Documentation & RCM

Commure Ambient AI Scores High Marks in KLAS First Look Report for Automating Provider Documentation & RCM

MOUNTAIN VIEW, Calif., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Commure, a leading healthcare technology company, today announced that its Commure Ambient AI solution has been spotlighted in a 2025 KLAS First Look Report for its ability to dramatically reduce …

Allogene Therapeutics Announces Participation in Upcoming Investor Conference

Allogene Therapeutics Announces Participation in Upcoming Investor Conference

SOUTH SAN FRANCISCO, Calif., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR T™) products for cancer and autoimmune disease, today …

Annexon Biosciences to Participate in Upcoming September Investor Conferences

Annexon Biosciences to Participate in Upcoming September Investor Conferences

BRISBANE, Calif., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company advancing a late-stage clinical platform of novel therapies for people living with devastating classical complement-mediated neuroinflammatory …

Global Virus Network Announces 2025 Rising Star Mentorship Program Awardees

Global Virus Network Announces 2025 Rising Star Mentorship Program Awardees

TAMPA, Fla., Aug. 27, 2025 (GLOBE NEWSWIRE) -- The Global Virus Network (GVN), a worldwide coalition of animal and human virologists spanning 80+ Centers of Excellence and Affiliates across more than 40 countries dedicated to advancing pandemic …

IBN Announces Latest Episode of The BioMedWire Podcast Featuring John Climaco, CEO of CNS Pharmaceuticals Inc.

IBN Announces Latest Episode of The BioMedWire Podcast Featuring John Climaco, CEO of CNS Pharmaceuticals Inc.

AUSTIN, Texas, Aug. 27, 2025 (GLOBE NEWSWIRE) -- -- via IBN -- IBN, a multifaceted communications organization engaged in connecting public companies to the investment community, is pleased to announce the release of the latest episode of The BioMedWire …

RAPT Therapeutics to Participate in Multiple Upcoming Investor Conferences

RAPT Therapeutics to Participate in Multiple Upcoming Investor Conferences

SOUTH SAN FRANCISCO, Calif., Aug. 27, 2025 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing novel therapies for patients living …

Septerna to Participate in Upcoming Investor Conferences

Septerna to Participate in Upcoming Investor Conferences

SOUTH SAN FRANCISCO, Calif., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Septerna, Inc. (Nasdaq: SEPN), a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) drug discovery, today announced that management will participate …

Design Therapeutics to Participate in the 2025 Cantor Global Healthcare Conference

Design Therapeutics to Participate in the 2025 Cantor Global Healthcare Conference

CARLSBAD, Calif., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Design Therapeutics, Inc. (Nasdaq: DSGN), a clinical-stage biotechnology company developing treatments for serious degenerative genetic diseases, today announced that management will participate in a …

Stanley Steemer Appoints Andrew Schneider as Head of Marketing and Selects Havas Chicago as Creative Agency

Stanley Steemer Appoints Andrew Schneider as Head of Marketing and Selects Havas Chicago as Creative Agency

Dublin, OH, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Stanley Steemer, the industry leader in deep whole-home cleaning, today announced the appointment of Andrew Schneider as Vice President and Head of Marketing. Schneider joins the company with a bold vision to …

Alignment Healthcare to Present at Morgan Stanley 23rd Annual Global Healthcare Conference and Baird 2025 Global Healthcare Conference

Alignment Healthcare to Present at Morgan Stanley 23rd Annual Global Healthcare Conference and Baird 2025 Global Healthcare Conference

ORANGE, Calif., Aug. 27, 2025 (GLOBE NEWSWIRE) --  Alignment Healthcare, Inc. (NASDAQ: ALHC), today announced that it will present at the following conferences in New York: Morgan Stanley 23rd Annual Global Healthcare Conference on Tuesday, Sept. 9, at 8: …

BIGC Raises $14M to Fuel Global Expansion of Its All-in-One Digital Venue Platform

BIGC Raises $14M to Fuel Global Expansion of Its All-in-One Digital Venue Platform

Introducing the Industry’s First All-in-One Digital Venue Technology for the Global Entertainment …

JLab Reveals Its 2025-2026 NIL Playmaker Roster Featuring Top College Football Athletes

JLab Reveals Its 2025-2026 NIL Playmaker Roster Featuring Top College Football Athletes

San Diego, Calif., Aug. 27, 2025 (GLOBE NEWSWIRE) -- JLab, leading personal technology and audio brand, today announced its 3rd roster of JLab Playmakers. Throughout the season, Playmakers will be featured across marketing campaigns and showcase a variety …

Belite Bio to Participate in Three Upcoming Investor Conferences

Belite Bio to Participate in Three Upcoming Investor Conferences

SAN DIEGO, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Belite Bio, Inc (NASDAQ: BLTE), a clinical-stage drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases that have significant unmet medical needs, today …

BridgeBio to Participate in September Investor Conferences

BridgeBio to Participate in September Investor Conferences

PALO ALTO, Calif., Aug. 27, 2025 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a new type of biopharmaceutical company focused on genetic diseases, today announced that members of its management team will host …

Rezolute to Participate in Upcoming Investor Conferences

Rezolute to Participate in Upcoming Investor Conferences

REDWOOD CITY, Calif., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT) (“Rezolute” or the “Company”), a late-stage rare disease company focused on treating hypoglycemia caused by hyperinsulinism, today announced that management will …

Abercrombie & Fitch Co. Reports Second Quarter Fiscal 2025 Results

Abercrombie & Fitch Co. Reports Second Quarter Fiscal 2025 Results

Delivers 11th consecutive quarter of growth, with record net sales of $1.2 billion, up 7% from last year, exceeding outlook Net sales growth led by Americas up 8%, APAC up 12%, partially offset by 1% decline in EMEA Hollister brands delivers its best ever …

Ventyx Biosciences to Participate in Three Upcoming Investor Conferences

Ventyx Biosciences to Participate in Three Upcoming Investor Conferences

SAN DIEGO, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Ventyx Biosciences, Inc. (Nasdaq: VTYX) (“Ventyx”, “Company”), a clinical-stage biopharmaceutical company focused on developing innovative oral therapies for patients with autoimmune, inflammatory, and …

ECARX Receives ASPICE v4.0 CL3 Certification, Reinforcing Global Expansion and Technology Leadership

ECARX Receives ASPICE v4.0 CL3 Certification, Reinforcing Global Expansion and Technology Leadership

SHANGHAI, Aug. 27, 2025 (GLOBE NEWSWIRE) -- ECARX (Nasdaq: ECX), a global mobility technology provider, today announced that its Antora® 1000 Pro computing platform has received Automotive SPICE (ASPICE) v4.0 Capability Level 3 (CL3) certification – the …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions